0 Commentaires
0 Parts
301 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
How Do Regulatory Fast-Track Approvals Influence the Oncology Drugs Market?Oncology Drugs Market: Growth, Trends, Key Companies & Future Outlook (2025–2033) The Oncology Drugs Market is on a strong upward trajectory, driven by innovations in cancer treatment, expanding patient populations, and ongoing advancements in biotechnology and pharmaceuticals. With an estimated market valuation of USD 253.6 billion in 2025, this sector is expected to...0 Commentaires 0 Parts 674 Vue 0 Aperçu
-
Newly Released: Chemotherapy Drugs Market Growth and Oncology Treatment Trends" Exactitude Consultancy That Adds Flavour To Your Success" Exactitude Consultancy has just rolled out its latest market research report titled "Chemotherapy Drugs Market. Market Size, Share, Growth Outlook & Industry Analysis Report: By Product Type (Antimetabolites, Alkylating Agents, Mitotic Inhibitors, Topoisomerase Inhibitors), By Application (Breast Cancer, Lung Cancer,...0 Commentaires 0 Parts 250 Vue 0 Aperçu
-
Oral HER Pathway Targeted Drugs Market Advances with Precision Oncology Developments"In-Depth Study on Executive Summary Oral HER Pathway Targeted Drugs Market Size and Share CAGR Value The global oral HER pathway targeted drugs market size was valued at USD 6.24 billion in 2025 and is expected to reach USD 15.01 billion by 2033, at a CAGR of 11.60% during the forecast period The Oral HER Pathway Targeted Drugs Market report contains...0 Commentaires 0 Parts 303 Vue 0 Aperçu
-
Spindle Cell Sarcoma Drugs Market – Targeted Oncology Therapies & Rare Cancer Treatment Progress"Executive Summary Spindle Cell Sarcoma Drugs Market Opportunities by Size and Share CAGR Value Data Bridge Market Research analyses that the global spindle cell sarcoma drugs market is expected which was USD 27030.00 million 2022 is expected to reach USD 43081.71 million 2030 to undergo a CAGR of 6.00% during the forecast period 2023-2030. The leading Spindle Cell Sarcoma Drugs...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Testicular Cancer Drugs Market Growth, Oncology Drug Development and Targeted Therapy Trends Forecast to 2033Introduction The testicular cancer drugs market is a crucial segment of the global oncology therapeutics industry, driven by advancements in cancer treatment and increasing awareness of early diagnosis. Testicular cancer, although relatively rare compared to other cancers, is one of the most common cancers among young men, particularly those between the ages of 15 and 35. The growing focus on...0 Commentaires 0 Parts 260 Vue 0 Aperçu
-
What Role Does AI Play in the Oncology Drugs Market Development?Oncology Drugs Market Overview: Trends, Growth, and Forecast 2025-2033 The oncology drugs market is one of the most dynamic and critical segments in the global pharmaceutical industry. As cancer remains a leading cause of mortality worldwide, the demand for innovative and effective oncology treatments continues to surge. According to recent market analysis, the oncology drugs...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Which Companies Dominate the Oncology Drugs Market in 2025?Oncology Drugs Market Overview 2025–2033: Size, Trends, Key Companies, Segments, and Growth Drivers The Oncology Drugs Market is one of the fastest-growing segments in the global pharmaceutical industry. According to the latest industry analysis, the global oncology drugs market size is projected to grow from USD 253.6 billion in 2025 to an impressive USD 580.2...0 Commentaires 0 Parts 940 Vue 0 Aperçu
-
Which Segment is Growing Fastest in the Oncology Drugs Market?Oncology Drugs Market Overview 2025–2033: Size, Growth Drivers, Key Segments, and Leading Companies The global Oncology Drugs Market is on the verge of remarkable expansion. According to the latest industry analysis, the oncology drugs market size is projected to grow from approximately USD 253.6 billion in 2025 to an impressive USD 580.2 billion by 2033,...0 Commentaires 0 Parts 971 Vue 0 Aperçu
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Commentaires 0 Parts 5KB Vue 0 Aperçu
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commentaires 0 Parts 497 Vue 0 Aperçu
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Commentaires 0 Parts 287 Vue 0 Aperçu
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Commentaires 0 Parts 276 Vue 0 Aperçu
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Commentaires 0 Parts 376 Vue 0 Aperçu
-
Is Synthetic Lethality the Future Breakthrough in Targeted Cancer Therapy?Executive Summary Synthetic Lethality Drug Market Size and Share Analysis Report CAGR Value The global Synthetic Lethality Drug market size was valued at USD 1.93 billion in 2025 and is expected to reach USD 8.07 billion by 2033, at a CAGR of 19.60% during the forecast period This Synthetic Lethality Drug Market research report guides the...0 Commentaires 0 Parts 610 Vue 0 Aperçu
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Commentaires 0 Parts 189 Vue 0 Aperçu
-
Will HER2 Inhibitors Continue to Revolutionize Targeted Cancer Therapy?HER2 Inhibitors Market Summary: According to the latest report published by Data Bridge Market Research, the HER2 Inhibitors Market CAGR Value With the clear understanding of customer requirement, one method or combination of many have been used to construct the most excellent HER2 Inhibitors Market research report. The report endows with complete market analysis and...0 Commentaires 0 Parts 141 Vue 0 Aperçu
Plus de résultats